Skip to main content
Log in

Reply to: “The strength of a randomized controlled trial lies in its design—randomization”

  • Letter to the Editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Pinto E, Nardi MT, Marchi R, Cavallin F, Alfieri R, Saadeh L, Cagol M, Baldan I, Saraceni E, Parotto M, Baratto F, Caberlotto C, Vianello A, Castoro C, Scarpa M (2021) QOLEC2: a randomized controlled trial on nutritional and respiratory counseling after esophagectomy for cancer. Support Care Cancer 29:1025–1033

    Article  Google Scholar 

  2. Efird J (2011) Blocked randomization with randomly selected block sizes. Int J Environ Res Public Health 8:15–20

    Article  Google Scholar 

  3. Pejovic NJ, Trevisanuto D, Lubulwa C, Myrnerts Höök S, Cavallin F, Byamugisha J, Nankunda J, Tylleskär T (2018) Neonatal resuscitation using a laryngeal mask airway: a randomised trial in Uganda. Arch Dis Child 103:255–260

    Article  Google Scholar 

  4. Sussman JB, Hayward RA (2010) An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials. BMJ. 340:c2073

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eleonora Pinto.

Ethics declarations

Ethics approval

Not required.

Consent to participate

Not applicable.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pinto, E., Scarpa, M. & Cavallin, F. Reply to: “The strength of a randomized controlled trial lies in its design—randomization”. Support Care Cancer 30, 4577–4578 (2022). https://doi.org/10.1007/s00520-022-06959-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-022-06959-x

Navigation